Influence of Sex, Age, and Tumor Genetics on Risk Assessment in Papillary Thyroid Carcinoma
-
By
-
Carmelo Nucera
-
September 29, 2026
Clinical Report: Influence of Sex, Age, and Tumor Genetics on Risk Assessment in Papillary Thyroid Carcinoma
Background
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer, and accurate risk stratification is crucial for effective management. Traditionally, age has been a key prognostic factor, while the role of sex has been debated. Recent advancements in molecular oncology have highlighted the importance of genetic mutations in determining tumor behavior.
Data Highlights
No numerical data available in the source material.
Key Findings
- Male sex is associated with higher PTC-specific mortality, particularly in tumors with BRAF V600E and TERT promoter mutations.
- The excess mortality risk for men is most pronounced in those aged 45 years or older with both mutations.
- Age remains a critical factor in the AJCC TNM staging system for predicting disease-specific mortality.
- Sex may act as a biological modifier rather than an independent prognostic marker in the context of tumor genetics.
- Previous studies have shown conflicting results regarding the prognostic significance of sex, likely due to a lack of consideration for molecular heterogeneity.
Clinical Implications
Clinicians should consider the interaction between sex, age, and tumor genetics when assessing the risk of mortality in PTC patients.
Conclusion
The findings indicate the importance of incorporating molecular characteristics alongside traditional demographic factors in PTC management.
Related Resources & Content
- Wu et al., JAMA Network Open, 2026 -- Gender Differences in Mortality Rates for Individuals with Papillary Thyroid Carcinoma
- American Thyroid Association, 2025 -- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
- ASCO Publications — Association of young patient age with high-risk pathologic features and recurrence in papillary thyroid cancer.
- Impact of Advanced Age on Mortality in Papillary Thyroid Carcinoma Patients with High-Risk Characteristics
- ASCO Publications — Patient Age–Associated Mortality Risk Is Differentiated by BRAF V600E Status in Papillary Thyroid Cancer
- 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer
- Sex and Mortality Among Patients with Papillary Thyroid Cancer | Oncology | JAMA Network Open | JAMA Network
- Prognostic Value of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis of Nodal Involvement, Distant Metastases, Recurrence, and Mortality - PubMed
Based on findings from:
Sex, Age, and Tumor Genetics to Inform Risk Stratification in Papillary Thyroid Cancer
Carmelo Nucera. Jama Network Open, 2026.
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854620
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
